Novel Stroke Risk Reduction Option for Indicated Patients with Atrial Fibrillation "With today's successful implantations of the WATCHMAN Device, we are changing the way we deal with stroke risk in ...

Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, targeted rollout,” one analyst said.

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Atrial Fibrillation - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. This "Atrial Fibrillation - Pipeline ...

Novel Stroke Risk Reduction Option for Indicated Patients with Atrial Fibrillation MARLBOROUGH, Mass., This week, four patients in the United States received the first implants of the Boston ...